Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Cerebral metabolic effects of intravenous glycine in healthy human subjects.

Neumeister A, Carson R, Henry S, Planeta-Wilson B, Binneman B, Maguire RP, Luckenbaugh DA, D'Souza C, Krystal JH, Frost JJ.

J Clin Psychopharmacol. 2006 Dec;26(6):595-9.

PMID:
17110816
2.

IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans.

D'Souza DC, Gil R, Cassello K, Morrissey K, Abi-Saab D, White J, Sturwold R, Bennett A, Karper LP, Zuzarte E, Charney DS, Krystal JH.

Biol Psychiatry. 2000 Mar 1;47(5):450-62.

PMID:
10704956
3.

Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.

Grossman R, Yehuda R, Golier J, McEwen B, Harvey P, Maria NS.

Ann N Y Acad Sci. 2006 Jul;1071:410-21.

PMID:
16891588
4.

Fluoxetine effects on cerebral glucose metabolism.

Cook EH Jr, Metz J, Leventhal BL, Lebovitz M, Nathan M, Semerdjian SA, Brown T, Cooper MD.

Neuroreport. 1994 Sep 8;5(14):1745-8.

PMID:
7827322
5.

Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.

Trevisan L, Petrakis IL, Pittman B, Gueorguieva R, D'Souza DC, Perry E, Limoncelli D, Krystal JH.

Alcohol Clin Exp Res. 2008 Jan;32(1):36-42. Epub 2007 Nov 20.

PMID:
18028532
6.

Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.

Matsumoto R, Haradahira T, Ito H, Fujimura Y, Seki C, Ikoma Y, Maeda J, Arakawa R, Takano A, Takahashi H, Higuchi M, Suzuki K, Fukui K, Suhara T.

Synapse. 2007 Oct;61(10):795-800.

PMID:
17598152
7.

Regional brain responses to serotonin in major depressive disorder.

Anderson AD, Oquendo MA, Parsey RV, Milak MS, Campbell C, Mann JJ.

J Affect Disord. 2004 Nov 1;82(3):411-7.

PMID:
15555692
8.

Global and regional cerebral metabolic rate of 2-[18F]fluoro-2-deoxy-D-glucose in the presence of ofloxacin, a gamma-aminobutyric acid a receptor antagonist.

Camargo EE, Sostre S, Sadzot B, Shafique I, Szabo Z, Links JM, Dannals RF, Wagner HN Jr.

Antimicrob Agents Chemother. 1991 Apr;35(4):648-52.

9.

The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers.

van Berckel BN, Lipsch C, Gispen-de Wied C, Wynne HJ, Blankenstein MA, van Ree JM, Kahn RS.

Psychopharmacology (Berl). 1998 Jul;138(2):190-7.

PMID:
9718289
10.

Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder.

Soloff PH, Meltzer CC, Becker C, Greer PJ, Constantine D.

Psychiatry Res. 2005 Apr 30;138(3):183-95.

PMID:
15854787
11.

Effects of lithium on brain glucose metabolism in healthy men.

Kohno T, Shiga T, Toyomaki A, Kusumi I, Matsuyama T, Inoue T, Katoh C, Koyama T, Tamaki N.

J Clin Psychopharmacol. 2007 Dec;27(6):698-702.

PMID:
18004140
12.

The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls.

Palmer C, Ellis KA, O'Neill BV, Croft RJ, Leung S, Oliver C, Wesnes KA, Nathan PJ.

Hum Psychopharmacol. 2008 Mar;23(2):151-9.

PMID:
17972276
13.

Behavioral and subjective effects of ethanol: relationship to cerebral metabolism using PET.

de Wit H, Metz J, Wagner N, Cooper M.

Alcohol Clin Exp Res. 1990 Jun;14(3):482-9.

PMID:
2198826
14.

Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes.

Herting B, Beuthien-Baumann B, Pöttrich K, Donix M, Triemer A, Lampe JB, von Kummer R, Herholz K, Reichmann H, Holthoff VA.

Mov Disord. 2007 Mar 15;22(4):490-7.

PMID:
17260333
15.

Evaluation of gender difference in regional brain metabolic responses to lorazepam.

Wang GJ, Volkow ND, Fowler JS, Hitzemann RJ, Pappas NR, Netusil N.

Psychiatry Res. 1998 Apr 10;82(1):37-46.

PMID:
9645549
16.

The changes of cortical metabolism associated with the clinical response to donepezil therapy in traumatic brain injury.

Kim YW, Kim DY, Shin JC, Park CI, Lee JD.

Clin Neuropharmacol. 2009 Mar-Apr;32(2):63-8. doi: 10.1097/WNF.0B013E31816F1BC1.

PMID:
18978490
17.

Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis.

Bragulat V, Paillère-Martinot ML, Artiges E, Frouin V, Poline JB, Martinot JL.

Psychiatry Res. 2007 Feb 28;154(2):115-24. Epub 2007 Feb 15.

PMID:
17306513
19.

A combined neuropsychological and brain imaging study of obstructive sleep apnea.

Yaouhi K, Bertran F, Clochon P, Mézenge F, Denise P, Foret J, Eustache F, Desgranges B.

J Sleep Res. 2009 Mar;18(1):36-48. doi: 10.1111/j.1365-2869.2008.00705.x.

20.

Pharmacokinetics of 8-hour intravenous infusion of NXY-059: a phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers.

Cheng YF, Jiang J, Hu P, Reinholdsson I, Guo W, Asenblad N, Nilsson D.

Clin Ther. 2008 Dec;30(12):2342-53. doi: 10.1016/j.clinthera.2008.12.013.

PMID:
19167593

Supplemental Content

Support Center